Latest News

New technology to monitor anti-drug antibodies in MS patients may have potential for COVID-19 testing




A new study led by Queen Mary University of London has demonstrated the effectiveness of using a novel light technology to monitor the presence of anti-drug antibodies in the treatment of multiple sclerosis, which can lead to drug resistance and treatment failure.

Source link

Related posts

Risk of coronavirus importation in Africa

Newsemia

Compression garments can ease lymphedema. Covering costs? Not so easy

Newsemia

Researchers identify molecular pathway underpinning exercise and improved motor learning

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World